Outcomes After Respiratory Virus Detection Prior to Pediatric Solid Organ Transplantation
Pediatric Transplantation · 2026-11 · 30 (11)
DOI: 10.1111/petr.70532 ↗Abstract
ABSTRACT Background Respiratory viral infections are associated with increased pulmonary morbidity in immunocompromised populations. It is not known whether pediatric solid organ transplant (SOT) recipients who test positive for respiratory viruses prior to transplant have increased risk of adverse pulmonary outcomes. Methods We conducted a single‐center retrospective study of pediatric SOT recipients tested for respiratory viruses by multiplex PCR in the 30 days prior to their transplant. Results Fourteen of 45 recipients who were tested had a virus identified, one of whom tested negative on a subsequent repeat test prior to transplant. The remaining 13 were matched 1:2 to control transplant recipients matched by age at transplant, organ transplanted, and date of transplant. No differences in adverse pulmonary outcomes were identified up to 90 days post‐SOT. A similar comparison of patients testing positive to 31 patients with negative respiratory virus testing also did not identify any differences in adverse pulmonary outcomes. Conclusions Among pediatric SOT recipients who underwent clinically indicated respiratory viral testing within 30 days prior to transplant, we did not observe a clear excess of post‐transplant pulmonary morbidity. Larger multicenter studies are needed to confirm this observation.
EUVIMED